Paradromics Email Formats
Biotechnology Research • 
Austin, Texas, United States • 51-100 Employees
Paradromics Email Formats
Paradromics uses 5 email formats. The most common is {first name}{last name} (e.g., johndoe@paradromics.com), used 53% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@paradromics.com | 53% |
{first initial}{last name} | jdoe@paradromics.com | 34.9% |
{first initial}.{last name} | j.doe@paradromics.com | 7.2% |
{f2}{last name} | {f2}doe@paradromics.com | 2.4% |
{last name}{last name} | doedoe@paradromics.com | 2.4% |
Key Contacts at Paradromics
Company overview
| Headquarters | Austin, Texas, United States |
| Phone number | +15125594120 |
| Website | |
| NAICS | 541714 |
| SIC | 384 |
| Keywords | Medical Devices, Neuroscience, Neurotechnology, BCI, Brain Computer Interface, Neural Interfaces, Assistive Communication Devices |
| Founded | 2015 |
| Employees | 51-100 |
| Socials |
About Paradromics
ENABLING NEUROTECHNOLOGY Paradromics’ Brain-Computer Interface (BCI) platform records brain activity at the highest possible resolution: the individual neuron. Our AI algorithms decode this massive amount of brain-data, enabling the seamless translation of thought into treatments. THE MISSION Data-driven BCI-based technologies for brain health Our technology will help millions with unmet medical needs suffering from paralysis and movement disorders to chronic pain, addiction, depression and other mental health conditions. ABOUT Matt Angle Ph.D. (CEO) founded Paradromics to build a high-data-rate BCI platform capable of addressing critical unmet clinical needs. With early funding from the NIH and DARPA, the company developed its core neurotechnology and, by 2019, shifted focus to its first product: the Connexus® BCI. Connexus is designed to restore communication through text, synthesized speech, and computer control for people with severe motor impairments, including those caused by ALS, stroke, or spinal cord injury. Backed by two FDA Breakthrough Device Designations and a successful first-in-human recording in May 2025, Paradromics is now preparing to launch a clinical trial in late 2025 to evaluate the long-term safety and participant benefits of their first product, the Connexus BCI.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Paradromics has 58 employees across 13 departments.
Departments
Number of employees
Paradromics Tech Stack
Discover the technologies and tools that power Paradromics's digital infrastructure, from frameworks to analytics platforms.
CDN
Security
JavaScript libraries
Tag managers
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
Page builders
JavaScript libraries
JavaScript libraries
Canada
Netherlands
Saudi ArabiaFrequently asked questions
4.8
40,000 users
